2025 年年度业绩公告点评：预告区间上沿， 贯彻长期主义 证券研究报告·海外公司点评·消费者主要零售商(HS) H&H 国际控股（01112.HK） | [Table_EPS] 盈利预测与估值 | 2024A | 2025A | 2026E | 2027E | 2028E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 13,052 | 14,354 | 16,042 | 17,970 | 20,073 | | 同比(%) | (6.28) | 9.97 | 11.76 | 12.02 | 11.71 | | 归母净利润（百万元） | (53.72) | 196.14 | 634.78 | 873.64 | 1,117.30 | | 同比(%) | (109.23) | 465.11 | 223.64 | 37.63 | 27.89 | | EPS-最新摊薄（元/股） | (0.08) | 0.30 | 0.98 | 1.35 | 1.73 | | P/E（现价&最新摊薄） | (131.66) | 36.06 | 11.14 | 8.10 | ...

Core Insights - The nutrition and health industry is currently in an adjustment phase, with declines in infant formula, intensified competition in adult nutrition, and structural differentiation in the pet segment. Despite this, the company achieved a revenue of 10.805 billion yuan in the first three quarters, reflecting a year-on-year growth of 12.3%, indicating stability [1] Group 1: Company Growth Strategy - The core value of the company lies not in a single product explosion but in the establishment of a "whole family nutrition health ecosystem" across infant, adult, and pet segments, extending the consumer lifecycle [1] - The company leverages maternal and infant channels, content marketing, and a comprehensive domestic and international e-commerce system to create a wide-reaching touchpoint network [1] - In the adult segment, Swisse has established clear positioning through a high-end and youthful product matrix across multiple subcategories [1] Group 2: International Market Structure - The company's international layout consists of three layers: - Core driving market (China) accounts for over 70% and remains the growth engine [2] - Mature markets (Australia and New Zealand) show stable growth, with Swisse maintaining a leading position and achieving an 8.9% growth [2] - Expanding markets (Southeast Asia, Middle East, Italy, etc.) are experiencing double-digit growth, representing potential future waves over the next three to five years [3] Group 3: Supply Chain and Operational Resilience - The company's supply chain system is crucial for supporting multi-market operations, with six R&D centers and multiple production bases facilitating resource sharing and raw material interchange [3] - The resilience of the supply chain allows the company to maintain stable gross margins during cost fluctuations and ensures product quality consistency within a global traceability system [3] Group 4: Long-term Investment Value - The company possesses three long-term value points: - A multi-category structure that reduces cyclical risks [4] - A multi-regional layout that enhances growth elasticity [4] - A high-end product mix that improves profitability and brand barriers [4] - As the industry transitions from an expansion phase to a refined competition phase, the company's systemic competitiveness in supply chain, internationalization, and brand matrix will be key to its sustained growth capability [4]

Investment Rating - The report does not explicitly provide an investment rating for the nutrition and health industry Core Insights - The nutrition and health food industry is rapidly growing due to increased consumer health awareness and rising disposable incomes, with a market size projected to grow from 1,038.03 billion RMB in 2019 to 1,376.58 billion RMB in 2024, reflecting a CAGR of 5.81% [9] - The industry is characterized by high gross margins, driven by the combination of fast-moving consumer goods attributes and pharmaceutical barriers, allowing brands to maintain high pricing power [5][10] - The demand for high-quality products is expected to continue growing, leading to an expansion of market share for premium offerings [5] Market Background - Nutrition health foods are categorized into health foods and functional foods, with health foods requiring certification and a "blue hat" mark, while functional foods are managed as regular foods [6] - The industry has evolved from a disorganized state to a regulated one, driven by policy guidance, technological innovation, and demand upgrades [7] - The COVID-19 pandemic has heightened health awareness among younger consumers, leading to a surge in demand for functional foods and beverages [8] Market Status - The market size is expected to grow from 1,444.28 billion RMB in 2025 to 1,821.34 billion RMB in 2029, with a CAGR of 5.97% [9] - The aging population and the rising incidence of chronic diseases are driving consumers to seek preventive health management solutions [9][12] - The market is characterized by a high concentration of top brands, with gross margins for self-owned brands in the nutrition health sector exceeding 45% [10] Market Competition - The competition in the nutrition health food market is fragmented, with many companies focusing on specific niches, leading to a low market concentration [16] - Top companies like Xianle Health and Tongrentang dominate the market due to their significant number of approved health food products [16] - The rise of e-commerce has transformed sales channels, with platforms like Douyin and Kuaishou becoming crucial for consumer education and product sales [17][18] Development Trends - The industry is witnessing diversification in product forms, with innovations in flavors and convenience, such as ready-to-eat formats [31] - Consumer trends indicate a shift towards daily health maintenance, with increasing frequency of product use among consumers [32] - There is a notable difference in advantages and disadvantages for pharmaceutical companies and regular food companies entering the nutrition health market, with pharmaceutical firms benefiting from brand trust and funding, while food companies leverage their customer base and rapid product iteration capabilities [34]